Zagreb, Croatia

Gordon Saxty

This inventor holds 1 USPTO granted patent and 4 published patent applications and 7 EPO patents. Top assignee: Astex Therapeutics Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gordon Saxty. Retrieved from https://idiyas.com/inventor/gordon-saxty-obgy3ex5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gordon Saxty: Innovator in Bicyclic Heterocycle Compounds

Introduction

Gordon Saxty is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on bicyclic heterocycle compounds.

Latest Patents

Gordon Saxty holds a patent for "Bicyclic heterocycle compounds and their uses in therapy." This invention relates to new bicyclic heterocycle compounds, pharmaceutical compositions comprising these compounds, and their application in treating diseases, including cancer. His work represents a crucial advancement in therapeutic options for serious health conditions.

Career Highlights

Gordon is associated with Astex Therapeutics Limited, a company known for its focus on innovative drug discovery and development. His role at Astex Therapeutics has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Gordon has collaborated with esteemed colleagues such as Gianni Chessari and Christopher Norbert Johnson. These partnerships have fostered a collaborative environment that enhances the potential for innovative discoveries in their field.

Conclusion

Gordon Saxty's work in developing bicyclic heterocycle compounds showcases his commitment to advancing therapeutic solutions for critical diseases. His contributions to Astex Therapeutics Limited and collaborations with other experts highlight the importance of teamwork in driving innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…